Sublingual isosorbide dinitrate for the detection of obstruction in hypertrophic cardiomyopathy
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
21821607
DOI
10.1093/ejechocard/jer115
PII: jer115
Knihovny.cz E-zdroje
- MeSH
- aplikace sublinguální MeSH
- hypertrofická kardiomyopatie patofyziologie MeSH
- isosorbiddinitrát * aplikace a dávkování MeSH
- lidé středního věku MeSH
- lidé MeSH
- obstrukce výtoku ze srdeční komory komplikace diagnostické zobrazování MeSH
- senzitivita a specificita MeSH
- vazodilatancia * aplikace a dávkování MeSH
- zátěžová echokardiografie * MeSH
- zátěžový test MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- isosorbiddinitrát * MeSH
- vazodilatancia * MeSH
AIMS: Hypertrophic cardiomyopathy (HCM) is predominantly associated with left ventricular outflow tract (LVOT) obstruction. The assessment of the obstruction with a provoking test should be a routine part of HCM evaluation. The aim of the study was to determine the utility of a sublingual spray application of isosorbide dinitrate (ISDN) for detection of an obstruction. METHODS AND RESULTS: We have prospectively analysed 77 consecutive HCM patients, measuring the LVOT gradient at rest, using the sublingual spray application of ISDN (2.5 mg; after 2, 5, and 10 min), and with exercise echocardiography. An obstruction was defined as a gradient ≥ 30 mmHg. An obstruction was present in 15 patients (19%) at rest, in 42 patients (55%) after ISDN, and in 55 patients (71%) after exercise. The ISDN test had a sensitivity of 76% and the specificity of 100% relative to exercise echocardiography, while at-rest measurements had a sensitivity of 27% and a specificity of 100%. The chronological difference in the prevalence of obstructions during the ISDN test was statistically significant (P < 0.05); at ISDN plus 2 min, obstructions were seen in only 29 patients (38%, gradient 28.8 ± 25.0 mmHg), however, at ISDN plus 5 and 10 min, obstructions were found in 42 patients (55%, gradient 44.5 ± 39.6 mmHg). CONCLUSION: The ISDN test is a reliable screening method for the detection of an HCM obstruction, however, the measurement should be delayed 5-10 min after the application of ISDN. Patients with negative ISDN tests should undergo exercise echocardiography.
Citace poskytuje Crossref.org
How to Treat Obstructions in Patients with Hypertrophic Cardiomyopathy